N
Natasha M. Ruth
Researcher at Medical University of South Carolina
Publications - 27
Citations - 672
Natasha M. Ruth is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 20 publications receiving 474 citations.
Papers
More filters
Journal ArticleDOI
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus
Rina Mina,Emily von Scheven,Stacy P. Ardoin,B. Anne Eberhard,Marilynn Punaro,Norman T. Ilowite,Joyce J. Hsu,Marisa S. Klein-Gitelman,L. Nandini Moorthy,Eyal Muscal,Suhas M. Radhakrishna,Linda Wagner-Weiner,M. L. Adams,Peter R. Blier,Lenore M. Buckley,Elizabeth C. Chalom,Gaëlle Chédeville,Andrew H. Eichenfield,Natalya Fish,Michael Henrickson,Aimee O. Hersh,Roger Hollister,Olcay Y. Jones,Lawrence Jung,Deborah M. Levy,Jorge M. Lopez-Benitez,Deborah McCurdy,Paivi Miettunen,Ana I. Quintero-Del Rio,Deborah Rothman,Ornella J Rullo,Natasha M. Ruth,Laura E. Schanberg,Earl D. Silverman,Nora G. Singer,Jennifer B. Soep,Reema H. Syed,Larry B. Vogler,Ali Yalcindag,Cagri Yildirim-Toruner,Carol A. Wallace,Hermine I. Brunner +41 more
TL;DR: To formulate consensus treatment plans (CTPs) for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in juvenile systemic lUPus erythematosus (SLE).
Journal ArticleDOI
Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
Norman T. Ilowite,Kristi Prather,Yuliya Lokhnygina,Laura E. Schanberg,Melissa E. Elder,Diana Milojevic,James W. Verbsky,Steven J. Spalding,Yukiko Kimura,Lisa Imundo,Marilynn Punaro,David D. Sherry,Stacey E. Tarvin,Lawrence S. Zemel,James D Birmingham,Beth S. Gottlieb,Michael L. Miller,Kathleen M. O'Neil,Natasha M. Ruth,Carol A. Wallace,Nora G. Singer,Christy Sandborg +21 more
TL;DR: To assess the efficacy and safety of rilonacept, an interleukin‐1 inhibitor, in a randomized, double‐blind, placebo‐controlled trial.
Journal ArticleDOI
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
Adriana Almeida de Jesus,Yangfeng Hou,Stephen R. Brooks,Louise Malle,Angelique Biancotto,Yan Huang,Katherine R. Calvo,Bernadette Marrero,Susan Moir,Andrew J. Oler,Zuoming Deng,Gina A. Montealegre Sanchez,Amina Ahmed,Eric J. Allenspach,Bita Arabshahi,Edward M. Behrens,Susanne M. Benseler,Liliana Bezrodnik,Sharon Bout-Tabaku,Anne Marie C. Brescia,Diane E. Brown,Jon M. Burnham,María Soledad Caldirola,Ruy Carrasco,Alice Y. Chan,Rolando Cimaz,Paul Dancey,Jason Dare,Marietta DeGuzman,Victoria R. Dimitriades,Ian Ferguson,Polly J. Ferguson,Laura S. Finn,Marco Gattorno,Alexei A. Grom,Eric P. Hanson,Philip J. Hashkes,Christian M. Hedrich,Ronit Herzog,Gerd Horneff,Rita Jerath,Elizabeth A. Kessler,Hanna Kim,Daniel J. Kingsbury,Ronald M. Laxer,Pui Y. Lee,Min Ae Lee-Kirsch,Laura B Lewandowski,Suzanne C. Li,Vibke Lilleby,Vafa Mammadova,Lakshmi N. Moorthy,Gulnara Nasrullayeva,Kathleen M. O'Neil,Karen Onel,Seza Ozen,Nancy Pan,Pascal Pillet,Daniela Gerent Petry Piotto,Marilynn Punaro,Andreas Reiff,Adam L Reinhardt,Lisa G. Rider,Rafael Rivas-Chacon,Tova Ronis,Angela Rösen-Wolff,Johannes Roth,Natasha M. Ruth,Marite Rygg,Heinrike Schmeling,Grant S. Schulert,Christiaan Scott,Gisella Seminario,Andrew I. Shulman,Vidya Sivaraman,Mary Beth F. Son,Yuriy Stepanovskiy,Elizabeth Stringer,Sara Taber,Maria Teresa Terreri,Cynthia J. Tifft,Troy R. Torgerson,Laura L. Tosi,Annet van Royen-Kerkhof,Theresa Wampler Muskardin,Scott W. Canna,Raphaela Goldbach-Mansky +86 more
TL;DR: The IRG-S expands the diagnostic armamentarium in evaluating USAIDs and points to different pathways regulating IRG expression as well as 3 additional autoinflammatory diseases: IL-18-mediated PAP and recurrent MAS, NEMO∆5-associated autoinflammatory syndrome (NEMO-NDAS), and SAMD9L- associated autoinflammatory disease (SAMD 9L-SAAD).
Journal ArticleDOI
Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.
Kathryn Phillippi,Mark F. Hoeltzel,Angela Byun Robinson,Susan Kim,Leslie Abramson,Eleanor S. Anderson,Mara L. Becker,Heather Benham,Timothy Beukelman,Peter R. Blier,Hermine I. Brunner,Joni Dean,Fatma Dedeoglu,Brian M. Feldman,Polly I. Ferguson,Donald P. Goldsmith,Beth Gottlieb,Thomas B. Graham,Thomas A. Griffin,Hilary M. Haftel,Gloria C. Higgins,J. R. Hollister,Joyce J. Hsu,Anna Huttenlocher,Norman T. Ilowite,Lisa Imundo,Rita S. Jerath,Lawrence Jung,Philip Kahn,Daniel J. Kingsbury,Kristin E. Klein,Marisa S. Klein-Gitelman,Sivia K. Lapidus,Thomas J. A. Lehman,Carol B. Lindsley,Michael A. Malloy,Deborah McCurdy,Eyal Muscal,Judyann C. Olson,Kathleen M. O'Neil,Karen Onel,Sampath Prahalad,Marilynn Punaro,C. Egla Rabinovich,Ann M. Reed,Sarah Ringold,Mary Ellen Riordan,Angela Byun Robinson,Deborah Rothman,Natasha M. Ruth,Kenneth N. Schikler,Nora G. Singer,Steven J. Spalding,Reema H. Syed,Kathryn S. Torok,Jenna Tress,Richard K. Vehe,Emily von Scheven,Lydia M. Walters,Jennifer E. Weiss,Pamela F. Weiss,Andrew J. White,Jennifer M. P. Woo,Ali Yalcindag,Lawrence S. Zemel +64 more
TL;DR: In this article, the relationship among race, income, and disease outcomes in children with juvenile dermatomyositis (JDM) was investigated. But, despite these differences in outcome measures, there were no significant differences among the racial groups in time to diagnosis or duration of disease.
Journal ArticleDOI
Advances in the care of children with lupus nephritis
TL;DR: International consensus exists for quality indicators for cSLE that consider the unique aspects of chronic disease in childhood and significant variation in evaluation and treatment has been addressed for proliferative forms of LN by development of consensus treatment practices.